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Abstract: This paper addresses the significant need for improvements in device version reporting
and practice across the academic and technical activity monitoring literature, and it recommends
assessments for new and updated consumer sensing devices. Reproducibility and data veracity are
central to good scholarship, and particularly significant in clinical and health applications. Across the
literature there is an absence of device version reporting and a failure to recognize that device validity
is not maintained when firmware and software updates can, and do, change device performance and
parameter estimation. In this paper, we propose the use of tractable methods to assess devices at their
current version and provide an example empirical approach. Experimental results for heart rate and
step count acquisitions during walking and everyday living activities from Garmin Vivosmart 3 (v4.10)
wristband monitors are presented and analyzed, and the reliability issues of optically-acquired heart
rates, especially during periods of activity, are demonstrated and discussed. In conclusion, the paper
recommends the empirical assessment of new and updated activity monitors and improvements in
device version reporting across the academic and technical literature.
Keywords: wearable sensing; activity monitoring; ambulatory heart rate; inter-instrument reliability
1. Introduction
Consumer wearable monitoring devices are used across a spectrum of health, well-being and
behavioral studies, as well as clinical trials. For example, the U.S. Library of Medicine ClinicalTrials.gov
database reports over 240 “Completed” to “Not yet recruiting” trials involving Fitbit devices (search
accessed 3 January 2019). However, the manufacturers of these devices are generally very clear that
Sensors 2019, 19, 5; doi:10.3390/s19010005 www.mdpi.com/journal/sensors
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activity trackers are not medical devices. For example, Garmin Vivosmart “Important Safety and
Product Information” [1] advises that the device is for “recreational purposes and not for medical purposes”
and that “inherent limitations” may “cause some heart rate readings to be inaccurate”, similarly, Fitbit
device “Important Safety and Product Information” declares that the device is “not a medical device”
and “accuracy of Fitbit devices is not intended to match medical devices or scientific measurement devices” [2].
However, given that these devices are being used in clinical applications, and with future clinical
applications anticipated [3], their validity and reliability are important.
In terms of meeting expectations, it is noteworthy that, at the time of writing, Fitbit’s motion
to dismiss a class action was recently denied. The complaint alleged “gross inaccuracies and recording
failures” [4] because “products frequently fail to record any heart rate at all or provide highly inaccurate
readings, with discrepancies of up to 75 bpm” [5].
This invited paper is an expansion of the work presented in [6] which proposed reliability
assessments of new and updated consumer-grade activity and heart rate monitors using
Garmin Vivosmart 3 activity trackers as exemplar devices to illustrate an assessment approach.
This paper is extended by the addition of step count results and Bland-Altman plots of heart rate
acquisitions, and, also, in the following sections with accounts of underlying reliability issues relevant
to ambulatory photoplethysmography and step counting.
1.1. Photoplethysmography (PPG)
Ambulatory optical heart rate acquisition from photoplethysmography (PPG) sensors is known
to be very challenging [7]. As illustrated in Figure 1, light emitted by PPG sensors is mostly absorbed
by body tissues. The amount of light reflected depends on several factors, one of which is the volume
of arteries near the skin’s surface. Blood in the arteries and arterioles absorbs light better than the
surrounding body tissues so, as they contract and swell in response to pulsating blood pressure,
the intensity of reflected light rises and falls.
Figure 1. Light reflectance in photoplethysmography (PPG) [8].
The reflected light variation due to arterial pulse waves is typically, at best, about 2% [9]. PPG
sensors detect this small variation in reflected light and use it to estimate heart rate. The effects of
movement at the sensor-skin interface can mean that simply walking can be enough to mask the
pulse signal. Indeed, one of the main challenges is the range of severe interference effects caused by
movement [10,11].
There are contrasting reports in the academic literature regarding consumer PPG heart rate
monitor validity; some studies conclude devices are valid [12], whilst others report on systematic
errors [13,14] or a scarcity of validation evidence [15], or recognize the multi-factorial nature of
device performance [16]. One option to reduce PPG sensitivity to movement is to adhere the sensor
over the carotid artery, but this is both intrusive and uncomfortable [17]. In addition to movement,
optical heart rate signals can also be affected by skin color [18] and aging [19]. Yet, optical heart rate
acquisition remains a desirable alternative to sensors such as electrocardiogram (ECG) chest straps
for consumer-level activity monitors, where comfortability, ease-of-use and low cost are prioritized.
It is, therefore, desirable that improvements in PPG heart rate estimation accuracy can be achieved in
further research.
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1.2. Step Counting
Step counting is a common function of consumer activity trackers. Step counts are estimated by
analyses of accelerometer data which is filtered to attempt to isolate features caused by steps from
those caused by other activities. Despite this filtering, erroneously logged steps can be produced by
non-step activities such as folding laundry [20] and other tasks and actions [21], particularly when
devices are worn on the dominant wrist. In addition to activity-induced false-positive step count
errors, false-negative step count errors are also reported in the literature when, for example, monitors
are used at slow walking speeds [21–23].
1.3. Device Selection, Assessment and Iteration
The selection of an appropriate activity monitor for a given study is typically determined by the
required parameter acquisitions and deployment needs [24] as well as the study budget. However,
the calibration and validation of devices [25,26] can be onerous. Best practice requires a substantial
time and resource investment for researchers to calibrate and validate sufficiently large numbers of
their devices with a large and diverse cohort of representative users performing a range of anticipated
activities. At the same time, commercial monitors can frequently and automatically update both
software and firmware that can alter device function, data collection and data reporting, all of which
have the potential to compromise previous validations. However, of course, manufacturers are under
no obligation to report the detail of their proprietary algorithms or the specifics of version changes.
Devices that have the same model name, but operate with different software and firmware
versions, are distinct devices; they should not be treated as identical devices. Ideally, devices would
be clearly differentiated in the literature with manufacturer, model and version data. While there
may be limited (if any) opportunity for researchers to reversion commercial device software to repeat
published experiments, the provision of version information would, at least, limit the potential for
incorrect aggregations of data for devices that operate with different software and firmware versions.
Unfortunately, there is a lack of studies in the literature comparing the performance of identical devices
using different software and/or firmware versions.
A number of studies have assessed and compared the validity and accuracy of different
monitoring device models [27–29]. However, across this literature, and in reviews of this literature [30],
it is common practice to provide version data for the software used for statistical analyses of
device performance, but it is not common practice to report version information for the devices
themselves. As an example of device ambiguity, a reference to “Garmin Vivosmart” could refer to
Garmin Vivosmart 4, Garmin Vivosmart 3 or Garmin Vivosmart HR. The date of a given publication
might help disambiguate the model variant but will not help identify the version. The Vivosmart HR
had 14 versions from 2.10 to 4.30 over approximately 30 months (each update comprising between 1
and 11 items, such as, “improved calculation of Intensity Minutes” and “Various other improvements”) [31].
At the time of the experimental work presented in this paper (May 2018), the Garmin Vivosmart 3
(v4.10) was the latest of nine versions and at the submission of this paper (January 2019) there had
been a further six updates and the release of a new Vivosmart 4 device which itself has received four
updates comprising 25 items.
The U.S. Food and Drug Administration has established a new ‘Digital Health Software
Precertification (Pre-Cert) Program’ [32] that aspires toward a more agile approach to digital health
technology regulation that recognizes the “iterative characteristics” of new consumer devices [33].
Ideally, study implementations of activity monitors would assess devices at their current ‘iteration’ and
maintain devices at that version throughout the study. If this were not desirable or practicable,
it would be preferable for update schedules to be controlled such that acquired data could be
differentiated accordingly.
Given that device performance and functionality can change with version updates and that these
updates can occur at frequent intervals, a tractable approach for assessing or reassessing devices is
desirable. In the following section we present an exemplar assessment for a new or updated device.
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The assessment approach exemplified here is not, and could not be, prescriptive. A useful approach
must incorporate participants and activities that have relevance to the intended study. It should also be
emphasized that a comprehensive validity and reliability assessment using calibration devices would
be preferable to the approach outlined here, but, the proposed sample-based approach is preferable to
no assessment at all.
2. Method and Materials
Four Garmin Vivosmart 3 activity trackers (all versioned SW v4.10 throughout data acquisitions
during May 2018) were worn, as shown in Figure 2, by four healthy researcher participants, P01-P04
outlined in Table 1, during (i) the treadmill walking activities summarized in Table 2 and (ii) 12 h
of everyday living. Two activity trackers were worn on each arm, both within the manufacturers
recommended region of the wrist. The walking speeds: slow, moderate, fast and vigorous, were
selected based on reports in the literature [34,35] and were performed on an h/p/cosmos Pulsar
treadmill. To support reproducibility [36], we report further details about materials in Appendix A.
Figure 2. Activity monitor positions (color-coded for reference).
In many activity monitoring experiments, especially where devices are reused by participants,
four devices will represent a sizable proportion of the total number of study devices and could
constitute a worthy lot sample. In larger scale experiments and studies where substantial numbers of
devices are to be deployed, and where more researcher time is available, larger test samples of devices
would be appropriate.
All participants reported regularly partaking brisk-intensive exercise outside largely sedentary
academic/working roles. Participant 1 was ambidextrous; all other participants were right-handed.
(Ethical approval for “Health Technology Assessment and Data Analytics”, ERP2329 was obtained
from Keele University and all participants gave their informed consent to take part.)
Table 1. Participant Summary
Participant Age (Years) Gender Height (m) Weight (kg) BMI
P01 25 Female 1.69 58 20.03
P02 54 Female 1.62 65 24.7
P03 47 Male 1.75 70 22.8
P04 28 Male 1.70 76 26.2
Table 2. The Treadmill Walking Activity Schedule
Time (Minutes) 20 20 20 20
Activity Slow Moderate Fast Vigorous
walking walking walking walking
(2.4 km/h) (3.2 km/h) (4.8 km/h) (6.4 km/h)
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Walking speeds were regulated by the researcher programming the treadmill speed as per the
schedule in Table 2. The slow walking activity was prefaced by two minutes of standing with arms
down. Pulse readings were taken from a Polar H10 chest strap ECG monitor at 1-min intervals
throughout the activity (one sample per minute is the fastest rate that the Vivosmart 3 devices log
heart rate data; a shorter interval would be more appropriate if assessing devices with a higher
sampling rate). Data (from logged Garmin .FIT files) was downloaded from the activity trackers
after each activity and converted into .CSV files and imported into Excel. Dates and times were
converted from the Garmin 16- and 32-bit timestamps used in the .FIT file [37] into standard Excel
date-time serial numbers. Mean Absolute Percentage Error (MAPE), the IntraClass Correlation (ICC)
and Bland-Altman plots, as commonly used in research reported in the literature [28,38], were used to
compare the heart rate recordings from the activity trackers with the ECG chest strap reference. Step
counts were also acquired from the trackers and between-device comparisons were made. Two-way,
mixed, single measures ICC variants for assessing absolute agreement and for assessing consistency,
as defined by McGraw and Wong [39], were applied.
3. Results
Figure 3 shows the heart rate recordings for P01-P04 from the treadmill walking activities.
Variability in recorded values can be seen at both slower and faster walking speeds and, notably,
differs between participants. For analysis of the acquired data we calculated the MAPE (compared
with the ECG chest strap reference) and ICC values listed in Table 3. As shown, treadmill acquisitions
for participants P02 and P03 produced higher MAPEs (including MAPEs over 10%: the level often
taken as the upper bound for “acceptable” errors) and lower ICCs. This could, in part, be attributed
to the increased age of participants P02 and P03 compared to P01 and P04. As shown in Figure 3,
for P02 there were some abnormally low but sparse heart rate recordings from the “blue” device and,
to a lesser extent, the “red” device. For P03, the “blue” device recorded decreasing heart rates when
the actual heart rate increased during the vigorous walking activity. This produced a near zero ICC.
Bland-Altman plots of the same data are shown in Figure 4.
Table 3. Values of Mean Absolute Percentage Error (MAPE) and IntraClass Correlation (ICC) From
Treadmill Walking Activities.
Participant Black Blue Green Red
ID MAPE ICC MAPE ICC MAPE ICC MAPE ICC
P01 7.08% 0.68 7.13% 0.71 4.34% 0.81 5.62% 0.90
P02 9.60% 0.69 15.55% 0.67 11.94% 0.58 13.42% 0.71
P03 13.00% 0.47 14.00% 0.02 16.00% 0.19 9.00% 0.84
P04 8.69% 0.84 6.14% 0.91 8.04% 0.86 7.57% 0.89
The Bland-Altman plots illustrate the substantial range of differences in heart rate estimation
between the devices and the ECG chest strap reference. As shown in Figure 4, the largest differences do
not occur at the highest average heart rates, but instead occur between approximately 90 and 120 bpm.
The diagonal clustering of points within this range is consistent with systematic errors caused by
interference from motion artifacts correlated with the walking rates of the participants (the average
step counts per minute of the participants were 106, 105, 102 and 115, respectively for P01-04). Thus,
the results shown in Figures 3 and 4 demonstrate how, even with small sample sizes of devices and
participants, the potential extent of erroneous readings is quickly revealed (i.e., large effects are visible
in small sample sizes; small effects are only revealed with large samples).
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Figure 3. Heart rate recordings acquired during treadmill walking activities.
Figure 4. Bland-Altman plots for each device compared with electrocardiogram (ECG) chest strap for
treadmill activities. Means (solid lines) and ±1.96SD levels (dashed lines) for each device are indicated.
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The devices were also worn by participants for 12-h periods during uncontrolled everyday living
activities. The recorded heart rates are shown in Figure 5. For all four participants, much of the day was
spent engaged in relatively sedentary activities corresponding to visibly closer agreements between
the devices. Periods of activity correspond to increases in heart rate and visibly decreased agreements
between the devices. Intraclass correlations and confidence intervals for treadmill walking and 12-h
use are plotted, respectively, in Figures 6 and 7. As anticipated, these indicate poor performance during
the treadmill activity. However, as shown in Figure 7, the devices performed more consistently during
the prolonged acquisitions of activities of everyday living, when activity levels were generally lower
on average.
Figure 5. Heart rate recordings acquired during 12 h of everyday living.
Step count data was also logged by each device. During the treadmill activity, estimated step
counts were in close agreement between devices. Figure 8 illustrates this consistency, showing the step
counts for all devices for a single participant (P03) during the treadmill activity. The devices do not
record step data as frequently as heart rate estimates, with gaps of up to 15 min between loggings. As a
result, there are only a small number of data points over the 80-min treadmill activity. One can observe,
in Figure 8, the near-linear relationship between steps and time indicating that, despite the walking
speed increasing every 20 min, the number of steps-per-minute remained approximately constant; it is
the length of stride that increases rather than the step rate.
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Figure 6. ICC for each device compared with ECG chest strap reference recordings with 90% confidence
intervals for treadmill activities.
Figure 7. Inter-instrument ICC values for 12 h of everyday living.
Figure 8. Example of ‘steps’ data (acquisition for participant P03 during treadmill activity).
For the 12-h everyday living recordings, Figure 9 shows a comparison of the total number of steps
logged by each device for each participant over the 12-h period. It is clear that participant P03 was
the most active during this period. In addition, for all participants, there is good agreement between
devices except for a tendency for the devices worn on the left hand (red and blue) to estimate fewer
steps than those on the right hand (black and green) as also found in [20,21]. This bias is particularly
evident in acquisitions for participants P01, P02 and P03 as illustrated in Figure 9(ii). In summary,
during treadmill walking there was poor heart rate agreement between devices but good step count
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agreement; during everyday living there was better heart rate agreement and slightly deteriorated
step count agreement.
Figure 9. Total steps logged over 12 h of everyday living, (i) absolute totals logged by each device for
each participant, (ii) percentage difference of device totals relative to the average logged step count for
each participant.
4. Discussion
As noted earlier, the assessment approach exemplified here is not prescriptive. A useful version
assessment approach must incorporate participants and activities that have relevance to the intended
study, otherwise, it would have little value. It is also important to ensure that the duration of activities
is sufficient for devices to record enough data. We established 20-min durations empirically for each
treadmill walking speed by monitoring the frequency of logged heart rate readings and expanding the
window to ensure several readings would be logged for each speed.
Of course, a comprehensive assessment using calibration devices (e.g., a 12-lead ECG and a
calibrated pedometer) would be preferable to the approach outlined here. Similarly, this empirical
approach is preferable to no assessment at all, or reliance on outdated, irrelevant or unreproducible
reports in the literature. We can imagine that the sample testing of new and updated devices could
provide some reassurance regarding device performance and reliability, and the practice usefully
propagated into wearable device applications, for example, applications of sampled wearable heart
rate estimates [40] and heart rate variability [41], and across the domain of consumer-level wearable
technology research.
Of the several limitations of the presented approach, there was, intentionally, a small number of
participants, a limited sample of unrepeated activities and there were no reference recordings for the
12-h everyday living activity. (Reference readings from finger-worn pulse oximeters were attempted,
but the devices repeatedly failed to maintain accurate readings). Additionally, the presented approach
cannot disambiguate the effects of inter-device variability and variability caused by wearing the device
in different positions. However, with just four participants and two activity acquisitions, we were
able to quickly and simply obtain an insight into the performance and reliability of the devices at their
Sensors 2019, 19, 5 10 of 13
current version, have an appreciation of their limitations and, also, a degree of confidence regarding
their potential for study acquisitions.
5. Conclusions and Further Work
There is considerable scope for further work to improve reproducibility across the activity
monitoring domain and to assist researchers evaluate and re-evaluate new and updated devices.
We have demonstrated an empirical approach to device assessment that provides an example
assessment that is not onerous and could be repeated without difficulty as and when devices
are updated.
Despite issues associated with reliable optical heart rate acquired from the wrist during activity,
we might hope that future and updated consumer devices would (i) be better at identifying erroneous
values and avoid reporting them and (ii) be better at correctly estimating values. However, it would be
unwise to assume every device upgrade will necessarily result in improved device performance in
all aspects.
In a systematic review of consumer-wearable activity trackers, Everson et al. [30], recommend
that “future studies on the measurement properties of the trackers should be sure to initialize the tracker properly
and indicate in the publication how this was done so others can replicate the process. Providing the specific
tracker type, date purchased, and date tested would also be important.” We additionally recommend that full
device details, including software and firmware versions, are reported in the literature. We further
recommend that there is some means to enable and encourage the sharing of version-by-version device
assessment data between manufacturers, users and researchers.
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Appendix A
The further material details were as follows:
• Garmin Vivosmart 3 software/firmware versions: SW: v4.10; TSC: v1.10; SNS: v5.90. Devices
were initialized according to the arm worn and all data was taken directly from logged .FIT
files. Devices were purchased on 9 March 2018 and acquisitions made during May 2018.
Their serial numbers were as follows: Black—560185378, Red—560185383, Blue—560640435,
Green—560639717.
• The treadmill was an h/p/cosmos Pulsar treadmill, h/p/cosmos Sports & Medical Gmbh,
Nussdorf-Traunstein, Germany. (cos100420b; ID: X239W80479043; OP19: 0319 1139)
• Polar H10 chest heart rate monitor (FCC ID: INW1W; Model: 1W; IC: 6248A-1W; SN:
C7301W0726005; ID: 14C00425; Firmware: 2.1.9 and data acquired via Polar Beat 2.5.3.
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